Sparkle of Hope Gala Chair KEVIN LOBO Chair and CEO Stryker
Sparkle of Hope Gala Chair MARK MCKENNA Chairman and CEO Mirador Therapeutics, Inc.
Mark C. McKenna is the founder, Chairman, and CEO of Mirador Therapeutics, and a renowned biotech entrepreneur, executive, and director known for his exceptional leadership and visionary approach. Mirador is a next-generation precision medicine company focused on developing first-in-class or best-in- class precision medicines for immunology and inflammation. Launched in 2024, Mirador has raised over $400 million plus
Kevin is Chair and Chief Executive Officer of Stryker, one of the world’s leading medical technology companies. Appointed CEO in October 2012 and Chair of the Board in July 2014, Kevin joined Stryker in 2011 and previously served as Group President of Orthopaedics. Under his leadership, Stryker has completed more than 60 acquisitions and advanced innovation and global market presence.
from leading life sciences investors and is based in San Diego, CA. Prior to Mirador, Mr. McKenna served as Chairman, President, and CEO of Prometheus Biosciences from 2019 until its acquisition by Merck for $10.8 billion in June 2023. Under his leadership, Prometheus raised over $1 billion in private and public financing, was recognized as the top-performing biotech IPO of 2021, and pioneered the first precision therapeutics clinical trial for immune-mediated diseases. This led to its acquisition by Merck, resulting in the largest buyout of company with a pre-Phase 3 asset to date. Prior to Prometheus Mr. McKenna was the President of Salix Pharmaceuticals and a corporate officer at Bausch + Lomb. There, he revitalized the gastroenterology business through strategic acquisitions and product launches, doubling revenue to over $2 billion and significantly enhancing operating margins. He also spent over a decade at Bausch + Lomb, where he was SVP and General Manager of the US Vision Care business. Mr. McKenna began his career at Johnson & Johnson, where he held several positions of increasing responsibility. He currently serves as the Chairman of Apogee Therapeutics, Inc. (Nasdaq: APGE) and is a board member of Spyre Therapeutics, Inc. (Nasdaq: SYRE) and New Amsterdam Pharma (Nasdaq: NAMS). In addition, Mr. McKenna is a Venture Partner at Arch and Senior Advisor to Fairmount Funds. Mr. McKenna holds a B.S. in marketing from Arizona State University and an MBA from Azusa Pacific University. Mr. McKenna also completed the Wharton’s Fellows Program at the University of Pennsylvania School of Business. Mr. McKenna is passionate about solving big problems in medicine and is regularly featured on CNBC’s Mad Money and Bloomberg radio. In addition, Mr. Mckenna is a frequent guest speaker at the Longwood Healthcare Conference and other industry thought leader
A recognized leader in innovation and workplace excellence, Kevin has been named to Forbes’ list of America’s Most Innovative Leaders, received the Ellis Island Medal of Honor (2023), and was honored with a CEO for All Leadership Award from Great Place to Work. During Kevin’s tenure with the company, Stryker’s strong emphasis on people and culture has earned it steady recognition as a Great Place to Work globally and across multiple categories, including the World’s Best Workplaces and the 100 Best Companies to Work For. With a career spanning finance, general management, and healthcare leadership across global markets, Kevin brings a wealth of strategic insight and operational expertise. Prior to Stryker, he held leadership roles at Johnson & Johnson, including President of Ethicon Endo Surgery, President of J&J Medical Products Canada, and CFO roles within its consumer and women’s health divisions. Earlier in his career, he held finance and management roles at Rhone-Poulenc, including assignments in Europe, as well as at Kraft Canada, Unilever, and KPMG. He serves on the Boards of Parker Hannifin (NYSE:PH) and the Advanced Medical Technology Association (AdvaMed) and is a member of the Business Council. Additionally, he serves as Chair of the Valley Health System’s board of trustees in New Jersey. Kevin holds a Bachelor of Commerce from McGill University, an MBA from the University of Toronto, and is a Chartered Accountant.
events. In 2023 he was selected as EY’s Entrepreneur of the year, being recognized for his contributions to advancement of entrepreneurship and science.
Made with FlippingBook - Online Brochure Maker